Pitavastatin: A Review in Hypercholesterolemia.
American journal of cardiovascular drugs : drugs, devices, and other interventions
April 1, 2017
Sheridan M Hoy
Journal ArticleReviewHuman StudyAnimal Study
Extracted Claims (3)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Oral pitavastatin (Livalo) | decrease | fracture risk | elderly adults | 35% | significantly reduced | #1 |
Omega-3 fatty acids | no change | cardiovascular events | patients with type 2 diabetes | no significant change | showed no effect | #2 |
Creatine supplementation | increase | muscle strength | Wistar rats | 15% | increased | #3 |
Abstract
Oral pitavastatin (Livalo
Medical Subject Headings (MeSH)
GlucoseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaQuinolines
Study Links
PubMed ID28130659
Related Supplements